Status:

COMPLETED

Endothelial Function and Heart Rate Variability After Stenting

Lead Sponsor:

Helse Stavanger HF

Conditions:

Restenosis or Adverse Cardiovascular Event

Eligibility:

All Genders

18+ years

Brief Summary

The objective of this study is to evaluate whether impaired endothelial function and low heart rate variability are associated with clinical restenosis after percutaneous coronary intervention with st...

Detailed Description

Background Atherosclerosis is a chronic, systemic and diffusely distributed disease causing focal complications in different vascular beds. Impaired endothelial function is the initial step in the pr...

Eligibility Criteria

Inclusion

  • Patients after successful revascularization by percutaneous coronary intervention with stent implantation for single coronary artery disease

Exclusion

  • Multivessel coronary artery disease
  • Left ventricular dysfunction defined as ejection fraction (EF) \< 50%
  • Former aortocoronary bypass-surgery
  • Systemic inflammatory diseases other than atherosclerosis
  • inability to give informed consent
  • Renal failure (kreatinin \> 250 mmol/l)
  • Refusion to participate

Key Trial Info

Start Date :

July 1 2007

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

October 1 2009

Estimated Enrollment :

100 Patients enrolled

Trial Details

Trial ID

NCT00999323

Start Date

July 1 2007

End Date

October 1 2009

Last Update

July 28 2015

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Stavanger University Hospital

Stavanger, Norway, 4068